Selank 11mg

Selank research focuses on its potential as a synthetic peptide for anxiety, cognitive, and neurodegenerative disorders, showing anxiolytic, nootropic, and neuroprotective effects by modulating neurotransmitters like GABA, serotonin, and dopamine, improving mood, memory, and stress response without benzodiazepine-like sedation. Developed from tuftsin, it’s approved in Russia for Generalized Anxiety Disorder (GAD) and exhibits immune support, but requires more international research despite promising preclinical and clinical data.

Key Research Areas & Findings

• Anxiolytic (Anti-Anxiety): Reduces anxiety and fear responses in animal models and GAD patients, acting on GABA receptors and affecting neurotransmitter balance.
• Nootropic (Cognitive Enhancement): Improves memory, learning, focus, and motivation by influencing genes related to neurotransmission and increasing BDNF (brain-derived neurotrophic factor).
• Neuroprotection: Protects neurons from oxidative stress, suggesting potential for neurodegenerative diseases like Alzheimer’s and Parkinson’s.
• Antidepressant & Antistress: Shows antidepressant-like effects and enhances stress tolerance, with effects on sleep-wake balance.
• Immunomodulation: Modulates immune responses by influencing cytokine levels and gene expression. 

Mechanism of Action

• Mimics the natural peptide tuftsin, enhancing stability.
• Influences gene expression for GABA receptors, dopamine, and serotonin systems.
• Modulates the balance between sleep and wakefulness by affecting orexin gene expression.
• Inhibits enzymes that break down endogenous peptides like enkephalins. 

Therapeutic Potential & Limitations

• Potential: Offers benefits like reduced anxiety without sedation, no habit-forming potential, and broader cognitive/immune support compared to traditional drugs.
• Limitations: Most research stems from Russia; more international validation and long-term safety data are needed; not FDA-approved